osi-027 and Scleroderma--Diffuse

osi-027 has been researched along with Scleroderma--Diffuse* in 1 studies

Other Studies

1 other study(ies) available for osi-027 and Scleroderma--Diffuse

Article	Year
Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma. The Journal of investigative dermatology, 2015, Volume: 135, Issue:11 Topics: Biomarkers; Biopsy, Needle; Cells, Cultured; Fibroblasts; Fibrosis; Humans; Imidazoles; Immunohistochemistry; Molecular Targeted Therapy; Phosphorylation; Polymerase Chain Reaction; Scleroderma, Diffuse; Sensitivity and Specificity; Sirolimus; Smad2 Protein; TOR Serine-Threonine Kinases; Transforming Growth Factor beta; Triazines	2015

Article

Year

Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma.

The Journal of investigative dermatology, 2015, Volume: 135, Issue:11

Topics: Biomarkers; Biopsy, Needle; Cells, Cultured; Fibroblasts; Fibrosis; Humans; Imidazoles; Immunohistochemistry; Molecular Targeted Therapy; Phosphorylation; Polymerase Chain Reaction; Scleroderma, Diffuse; Sensitivity and Specificity; Sirolimus; Smad2 Protein; TOR Serine-Threonine Kinases; Transforming Growth Factor beta; Triazines

2015